2022
DOI: 10.1002/bdr2.2075
|View full text |Cite
|
Sign up to set email alerts
|

Identifying the landscape of developmental toxicity new approach methodologies

Abstract: Background The dynamics and complexities of in utero fetal development create significant challenges in transitioning from lab animal‐centric developmental toxicity testing methods to assessment strategies based on new approach methodologies (NAMs). Nevertheless, considerable progress is being made, stimulated by increased research investments and scientific advances, such as induced pluripotent stem cell‐derived models. To help identify developmental toxicity NAMs for toxicity screening and potential funding … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…Some advantages of working with SMOs for DART studies is the ability to quickly study the direct effects of chemicals on progeny in the absence of maternal metabolism and toxicity, the vast amount of information available about their embryology, and the opportunity to work with complete embryo models instead of less complex cell culture models [ 13 ]. As attention is increasingly being focused on designing integrated approaches to DART testing and assessment using NAMs, SMO-based assays can be used as a complementary component to cell-based assays and existing mammalian DART studies in support of safety assessment, hazard identification, and regulatory decision making [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Some advantages of working with SMOs for DART studies is the ability to quickly study the direct effects of chemicals on progeny in the absence of maternal metabolism and toxicity, the vast amount of information available about their embryology, and the opportunity to work with complete embryo models instead of less complex cell culture models [ 13 ]. As attention is increasingly being focused on designing integrated approaches to DART testing and assessment using NAMs, SMO-based assays can be used as a complementary component to cell-based assays and existing mammalian DART studies in support of safety assessment, hazard identification, and regulatory decision making [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…The rate of toxicological testing has not yet caught up to the rate of new chemicals being commercially introduced (Daston et al, 2022;Krewski et al, 2020). It is therefore imperative that rapid, reliable, and affordable higher-throughput toxicity screening methods be developed (Bal-Price, Hogberg, et al, 2018;Becker et al, 2022;Maertens et al, 2021). US government initiatives support the development and evaluation of new approach methodologies (NAMs) for use in hazard identification for regulatory purposes (EPA, 2020;FDA, 2017).…”
Section: Introductionmentioning
confidence: 99%